https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Cervical Spine Procedures

Showing all 8 results

Orthobiologics Market Analysis, Size, Trends | China | 2020-2026 | MedSuite

In 2020, the Chinese orthobiologics market size was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026. Throughout this medical market research, we analyzed 28 orthobiologics companies across China

more...

Orthobiologics Market Analysis, Size, Trends | India | 2020-2026 | MedSuite

In 2020, the Indian orthobiologics market size was valued at $76.2 million, with over 520,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 12.4% to reach $172.3 million in 2026. Throughout this medical market research, we analyzed 23 orthobiologics companies across India

more...

Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite

In 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR). Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our

more...

Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite

In 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026. Throughout this medical market research, we analyzed 16 orthobiologics companies across

more...

Orthobiologics Market Analysis, Size, Trends | Australia | 2020-2026 | Medsuite

In 2020, the Australian orthobiologics market size was valued at $63.8 million, with over 29,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 4.9% to reach $89.4 million in 2026. Throughout this medical market research, we analyzed 48 orthobiologics companies across Australia

more...

Orthopedic Biomaterials Market Size, Share and COVID-19 Impact Analysis | Global | 2023-2029 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

Overall, the global orthopedic biomaterials device market was valued at $5.6 billion in 2022. This is expected to increase over the forecast period at a CAGR of 3.4% to reach $7.1 billion.

more...

Orthopedic Biomaterials Market Size, Share and COVID-19 Impact Analysis | Europe | 2022-2028 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

The European Orthopedic Biomaterials market report covers and includes the Bone Graft Substitutes Market, Orthopedic Growth Factor Market , Orthopedic Cell Therapy Market, Hyaluronic Acid Viscosupplementation Market, and the Orthopedic Cartilage Repair Market.

more...

Orthopedic Biomaterials Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Orthopedic Bone Graft Substitutes (Allografts, Demineralized Bone Matrices (DBMs), Xenografts, and Synthetic Bone Graft) , Orthopedic Growth Factor, and 4 more

Overall, the U.S. Orthopedic Biomaterials market was valued at $3.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $4.7 billion. Demographic factors in the U.S. continue to be the largest driver within the orthopedic biomaterials market. This is primarily due to the growing elderly

more...